Navigation Links
Jenny Craig Announces Finalists for the 2008 Ideal Size Contest
Date:10/29/2008

Grand Prize winner to appear in nationally-aired commercial with Jenny Craig celebrity client, Valerie Bertinelli

CARLSBAD, Calif., Oct. 29 /PRNewswire/ -- Jenny Craig is pleased to announce the three grand finalists of their Ideal Size Challenge. Washington's Debbie Heyer and Massachusetts natives Elaina Faustino and Sara Hennessy are the three women vying for the chance to appear in a national TV commercial with Jenny Craig star client, Valerie Bertinelli, and share their Ideal Size with the country.

Unlike the conventional view of size, Jenny Craig developed the Ideal Size Challenge to inspire women and men to stop looking at size as a number on the scale or a dress size, and to start seeing their Ideal Size as a significant achievement relating to how they would feel once they achieved their weight loss goal. Examples are "Size Healthier" or "Size Loving Life".

"Ideal Size is as much about how you feel on the inside. It represents the complete transformation that weight loss can bring--improved health, energy, confidence and well-being," says Scott Parker, Vice President of Marketing for Jenny Craig. "We want women and men to start defining size as something that's unique and personal to them."

Jenny Craig star client, and the face of the Ideal Size campaign, Valerie Bertinelli, has defined herself as a "Size Confident" urging more women to banish the numbers and start doing what feels right to them. "I am so thrilled to see how far these women have come, and I know that their hard work and candor will inspire many others to throw out their antiquated ideas and stereotypes of beauty and body image," says Valerie.

The Finalists:

Just like Valerie, the three finalists have coined monikers that best represents how they categorize themselves after their weight loss efforts.

Debbie Heyer, a "Size Fit and Fabulous" has lost over 200 pounds on the Jenny Craig plan and is thrilled to be able to shop in any clothing
'/>"/>

SOURCE Jenny Craig
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Jenny McCarthy and Lance Armstrong Top Celebrity List to Raise Funds for Autism
2. Global Health Trax Joins Fight Against Autism With Jenny McCarthy and Generation Rescue
3. Jenny Craig Establishes License Agreement for Volumetrics(R)
4. Jenny McCarthy & Jim Carrey Host the Historic Green Our Vaccines March and Rally in Washington DC on June 4, 2008
5. Generation Rescue to Target Treatment-Based Research for Autism and ADHD - Jenny McCarthy, Deirdre Imus, and Katie Wright Join Board
6. TV Personality and Best-Selling Author Jenny McCarthy Comes to Detroit to Share Her Story of the Struggles and Triumphs of Raising Her Son, Evan, During a Day-Long Autism Workshop
7. Jenny Craig Offers Help to Stranded Clients
8. Video Feed: Jenny McCarthy Honored at LEGOLAND(R) Californias Tree Lighting Ceremony Dedicated to Autism Awareness
9. Jenny McCarthy Featured at National Autism Conference in Atlanta, November 9
10. Queen Latifahs Travlin Light Tour to Be Sponsored by Jenny Craig
11. Craig W. Philips Takes Helm at CTI

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...Nov.27/PRNewswire-USNewswire/--Consideredahighlyri...solidorgantransplantationisnowalife-savingmainstre...atheredattheWinspearOperaHouseinDallasonNov.11.Lea...celebratethe25thanniversaryofBaylorRegionalTranspl...nsplantintheUnitedStates. ,, Itwas25yearsagotha...
(Date:11/27/2009)... XenaCare Holdings has announced that it...undation, one of the largest nonprofit organizatio...th education. , Delray Be...ings, Inc. (OTCBB: XCHO), a company specializing i...r healthcare products, has announced today that is...
(Date:11/27/2009)... Multi-purpose bilingual coloring books ...se by the business community to educate - inform p... from Safety issues to Dinosuars to ABC,S and a ho...nt Louis, MO (PRWEB) November 27, 2009 -- Today&rs... toys to keep them busy any hour of the day, but o...
(Date:11/26/2009)...5 years, the number of Americans living with diabe...on in 2009 to 44.1 million in 2034. Over the same ...ising from $113 billion to $336 billion, even with...hers based at the University of Chicago report in ...ber of those with diabetes covered by Medicare wil...
(Date:11/26/2009)... Dr. David Kim of the Live Life Again Ce...Dallas , is one of a growing number of physicians ...king sites to connect with individuals who are int... morbid obesity. Dr. Kim is utilizing Facebook to ...t his practice with the community. , ...
Breaking Medicine News(10 mins):Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 2Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3
...IS, July 1 Uroplasty, Inc. (Amex:,UPI), a medical...rkets,innovative proprietary products for the trea... it was added to the Russell Microcap(R) Index whe... which remains in place for one,year, means automa...
...LIS, July 1 CoLucid Pharmaceuticals, Inc., an,inn...s for central nervous,system disorders, announced ...vestor Care Capital led the round, which included ...r develop a,unique migraine compound, COL-144, and...
... New research shows that a majori... pay higher taxes to fund increased education faci...d consumer attitudes to the recruitment of nurses ...are survey are concerned about the on-going effect...
...ELPHIA In the first study of its kind, researcher...Medicine,s Ross Koppel, Ph.D. studied how hospital...ches the right patient with the right dose of the ...tion administration errors, is flawed, and can inc...
...follow-up to research showing that psilocybin, a s... substantial spiritual effects, a Johns Hopkins te... last more than a year. , Writing in the Journa... Hopkins study published in 2006, continued to say...
...E, N.J., June 30 Janssen, Division,of Ortho-McNei... has,launched an authorized generic version of RIS...icals, L.L.C., Patriot is a subsidiary of McNeil-...RISPERDAL, which was first approved by the FDA in ...
Other Medicine News:Health News:Uroplasty Joins the Russell Microcap Index 2Health News:Uroplasty Joins the Russell Microcap Index 3Health News:CoLucid Pharmaceuticals Announces $25 Million Series B Financing for Advancement of First-in-Class Migraine Compound 2Health News:CoLucid Pharmaceuticals Announces $25 Million Series B Financing for Advancement of First-in-Class Migraine Compound 3Health News:CoLucid Pharmaceuticals Announces $25 Million Series B Financing for Advancement of First-in-Class Migraine Compound 4Health News:Education More Important Than Immigration to Solve Nursing Shortage, Research Shows 2Health News:Education More Important Than Immigration to Solve Nursing Shortage, Research Shows 3Health News:Flaws in the barcoded technology used to reduce medication administration errors identified 2Health News:Flaws in the barcoded technology used to reduce medication administration errors identified 3Health News:Flaws in the barcoded technology used to reduce medication administration errors identified 4Health News:Spiritual effects of hallucinogens persist, Johns Hopkins researchers report 2Health News:Janssen Announces Launch of Authorized Generic for RISPERDAL(R) 2Health News:Janssen Announces Launch of Authorized Generic for RISPERDAL(R) 3Health News:Janssen Announces Launch of Authorized Generic for RISPERDAL(R) 4
(Date:11/25/2009)...DGE, N.J., Nov. 25 Regado Bioscien...ent of antithrombotic aptamers with active control...President, will be presenting at the Piper Jaffray...k Palace Hotel in New York City. Dr. Mazzo,s pres... December 1 and will include an overview of the Co...
(Date:11/25/2009)...ORK, Nov. 25 Reportlinker.com anno...le in its catalogue: ,, Mammography Equipment....reportlinker.com/p0164330/Mammography-Equipment--...cidence of breast cancer in industrialized as well...encing growth in the mammography market. Globally,...
(Date:11/25/2009)...AM, Mass., Nov. 25 According to Mi...y on medical technology market intelligence, the n...ices will continue to see rapid growth over the ne.... MRG,s US Markets for Trauma Devices 2010 rep...mic over the next five years, with competitors int...
Breaking Medicine Technology:Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 4Reportlinker Adds Mammography Equipment - A Global Market Perspective 5Reportlinker Adds Mammography Equipment - A Global Market Perspective 6Reportlinker Adds Mammography Equipment - A Global Market Perspective 7Reportlinker Adds Mammography Equipment - A Global Market Perspective 8US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3This Summer is an Ideal Time for Commercial Real Estate Lease Renewal 53022 1This Summer is an Ideal Time for Commercial Real Estate Lease Renewal 53022 2This Summer is an Ideal Time for Commercial Real Estate Lease Renewal 53022 3PATH Malaria Vaccine Initiative and Crucell to test new malaria vaccine approach 53020 1PATH Malaria Vaccine Initiative and Crucell to test new malaria vaccine approach 53020 2SAFC Biosciences 28R 29 Defines Hydrolysate Components That Enhance Chinese Hamster Ovary 28CHO 29 Cell Line Protein Production 13241 1SAFC Biosciences 28R 29 Defines Hydrolysate Components That Enhance Chinese Hamster Ovary 28CHO 29 Cell Line Protein Production 13241 2SAFC Biosciences 28R 29 Defines Hydrolysate Components That Enhance Chinese Hamster Ovary 28CHO 29 Cell Line Protein Production 13241 3SAFC Biosciences 28R 29 Defines Hydrolysate Components That Enhance Chinese Hamster Ovary 28CHO 29 Cell Line Protein Production 13241 4
...IOPHARM Oncology,Inc. (NASDAQ: ZIOP), announced t...nnual International Myeloma Workshop being,held in...highlights,important advances made in the biology ...senting darinaparsin (ZIO-101) gene,expression pro...hanism of action as well as interim Phase II data ...
...CADE, lenalidomide,and dexamethasone , ,KOS, Greec...armaceuticals, Inc. (Nasdaq: MLNM) today reported ...trials of VELCADE based,therapies that showed cons...mplete response(1) (CR) rates in newly diagnosed,m...sented at the,prestigious 11th International Myelo...
Other Medicine Technology:ZIO-101 (Darinaparsin) Interim Phase II and Preclinical Data,Presented at International Myeloma Workshop 2ZIO-101 (Darinaparsin) Interim Phase II and Preclinical Data,Presented at International Myeloma Workshop 3ZIO-101 (Darinaparsin) Interim Phase II and Preclinical Data,Presented at International Myeloma Workshop 4Velcade (bortezomib) for Injection Based Therapies Achieved,Survival Rates as High as 100 Percent in Newly Diagnosed Multiple,Myeloma Patients 2Velcade (bortezomib) for Injection Based Therapies Achieved,Survival Rates as High as 100 Percent in Newly Diagnosed Multiple,Myeloma Patients 3Velcade (bortezomib) for Injection Based Therapies Achieved,Survival Rates as High as 100 Percent in Newly Diagnosed Multiple,Myeloma Patients 4Velcade (bortezomib) for Injection Based Therapies Achieved,Survival Rates as High as 100 Percent in Newly Diagnosed Multiple,Myeloma Patients 5Velcade (bortezomib) for Injection Based Therapies Achieved,Survival Rates as High as 100 Percent in Newly Diagnosed Multiple,Myeloma Patients 6Velcade (bortezomib) for Injection Based Therapies Achieved,Survival Rates as High as 100 Percent in Newly Diagnosed Multiple,Myeloma Patients 7Velcade (bortezomib) for Injection Based Therapies Achieved,Survival Rates as High as 100 Percent in Newly Diagnosed Multiple,Myeloma Patients 8
Sealing Mat for 384-well PCR plate
...pha unit, these new pads may be used in applicatio...essive runs may be sealed with the same pad. The M...te from sticking to the block and lid, and Microse...rformance, which means you can use as little as 50...
...pha unit, these new pads may be used in applicatio...essive runs may be sealed with the same pad. The...late from sticking to the block and lid, and Micro...performance, which means you can use as little as ...
Microseal 'M' mats
Medicine Products: